What are the recommended intramuscular dosing guidelines, administration technique, contraindications, and monitoring parameters for haloperidol injection used for rapid control of severe agitation or acute psychosis in adults and adolescents?

Haloperidol Injection for Acute Agitation and Psychosis

Primary Recommendation: Avoid Haloperidol as First-Line

Atypical antipsychotics such as IM olanzapine 10 mg or IM ziprasidone 20 mg should be used instead of haloperidol for rapid control of severe agitation or acute psychosis, offering equivalent or superior efficacy with significantly fewer extrapyramidal side effects and better cardiac safety profiles. 1

---

When Haloperidol Must Be Used: Dosing Guidelines

Adults (Under 65 Years)

• IM haloperidol 5 mg is the traditional dose for acute agitation, with onset of action within 30 minutes and peak effect at 20-40 minutes 2, 3
• Repeat doses of 5 mg IM can be given every 30-60 minutes based on clinical response, up to 6 injections within 12 hours if needed 3
• Combination therapy with lorazepam 2 mg IM plus haloperidol 5 mg IM produces the most rapid tranquilization, with superior results at 1-3 hours compared to either agent alone 3

Older Adults (≥65 Years)

• Start with 0.5 mg IM or IV in elderly patients, as this low dose demonstrates similar efficacy to higher doses with better outcomes 4
• Patients receiving ≤0.5 mg haloperidol had shorter length of stay, less restraint use, and better discharge outcomes compared to those receiving higher doses 4
• Maximum initial dose should not exceed 1 mg in older or medically compromised patients 4

Adolescents

• Use the lowest effective dose, typically starting at 2-3 mg IM, though specific adolescent dosing data is limited in the evidence provided
• Young age is a significant risk factor for acute dystonic reactions, requiring heightened vigilance 5

---

Administration Technique

Route Selection

• IM injection is preferred over IV in emergency settings due to established safety profile 2
• IV administration is off-label but widely used in ICU settings, particularly for continuous infusions in severe delirium 6
• Avoid IM diazepam due to erratic and incomplete absorption 1

Monitoring During Administration

• Obtain baseline ECG before administration if any cardiac risk factors are present, as haloperidol prolongs QTc by approximately 7 ms 1
• Monitor for QT prolongation during therapy, especially with continuous IV infusions 6
• Close monitoring for rhythm disturbances is mandatory with IV haloperidol 6

---

Absolute Contraindications

• Parkinson's disease or dementia with Lewy bodies due to severe risk of extrapyramidal symptoms 1
• QTc interval >500 ms or known QTc-associated cardiac conditions 7
• Cardiomyopathy or significant cardiac disease, where olanzapine (2 ms QTc prolongation) is vastly safer than haloperidol (7 ms prolongation) 1

---

Critical Monitoring Parameters

Immediate (First 30-60 Minutes)

• Acute dystonic reactions typically occur within 12-26 hours of first dose, presenting as involuntary spastic muscle contractions affecting face, neck, back, or limbs 5
• Oculogyric crisis (upward eye deviation with inability to lower gaze) requires immediate anticholinergic treatment 5
• Laryngeal dystonia (choking, difficulty breathing, stridor) is life-threatening and requires urgent airway assessment 5
• Risk factors for dystonia include young age, male gender, and high-potency antipsychotic use 5

Ongoing Monitoring

• Extrapyramidal symptoms at every clinical contact, as these predict poor long-term medication adherence 1
• Blood pressure for orthostatic hypotension, particularly in elderly patients 1
• Cardiac rhythm if IV route is used or in patients with cardiac risk factors 6

---

Management of Acute Dystonic Reactions

First-Line Treatment

• Benztropine 1-2 mg IM/IV provides rapid relief within minutes 5
• Diphenhydramine 25-50 mg IM/IV is equally effective as an alternative 5

Severity-Based Dosing Algorithm

• Mild to moderate dystonia: Benztropine 1 mg IM/IV or diphenhydramine 25 mg IM/IV 5
• Severe dystonia: Benztropine 2 mg IM/IV or diphenhydramine 50 mg IM/IV 5
• Life-threatening laryngeal dystonia: Benztropine 2 mg IV plus immediate preparation for airway management 5

Prevention Strategy

• Consider prophylactic anticholinergic agents for high-risk patients (young, male, history of dystonic reactions) to prevent compliance-damaging negative experiences 5

---

Why Alternatives Are Superior

IM Olanzapine 10 mg

• Equivalent efficacy to haloperidol 7.5 mg IM with onset within 15-30 minutes 1, 7
• Superior tolerability with significantly fewer extrapyramidal symptoms 7
• Safest cardiac profile with only 2 ms QTc prolongation versus 7 ms for haloperidol 1
• Avoid combining with benzodiazepines due to risk of oversedation and respiratory depression 8

IM Ziprasidone 20 mg

• Rapid onset within 15 minutes with notably absent movement disorders 1, 7
• Contraindicated if QTc >500 ms due to variable QTc prolongation (5-22 ms) 1

Combination Therapy for Cooperative Patients

• Oral risperidone 2 mg plus lorazepam 2 mg produces equivalent efficacy to IM haloperidol plus lorazepam with significantly less excessive sedation 1

---

Common Pitfalls to Avoid

• Using haloperidol in elderly patients without dose reduction leads to worse outcomes; always start at ≤0.5 mg 4
• Failing to obtain baseline ECG in cardiac patients before haloperidol administration 1
• Not having anticholinergics immediately available when administering haloperidol to young patients 5
• Combining IM olanzapine with benzodiazepines, which has been associated with fatalities 7
• Using thioridazine (25-30 ms QTc prolongation) when any antipsychotic is needed 1